Recent studies have caused concern regarding the long term neurological outcome of preterm infants with hypothyroxinemia (New Engl J 334:821-827, 1996) & full term infants with thyroxine treated congenital hypothyroidism(hypoT) (Ped Res 39:561-566, 1996). To understand the metabolic mechanisms underlying hypoT induced adverse effects upon neurological function, we previously examined its effect upon brain glucose transporters and noted a 50% decline (Ped Res 39:91A, 1996). In this study we investigated the expression and role of the hexokinase I (hxl) enzyme which mediates brain glucose phosphorylation, a rate limiting process critical for brain cellular growth, maturation and oxidative metabolism. Employing the hyt/hyt mouse which expresses a native mutation (Pro556→Leu) of the TSH receptorβ-subunit and presents phenotypically with congenital primary hypoT (Endo 136:1346-1353, 1995) & the Balb-C (+/+) mouse as the control, we examined the brain hxl mRNA (Northern blot), protein concentrations (Western blot), enzymatic activity (NADP→NAPH spectrophotometric assay) & function(brain 3H-2deoxy[2-D] glucose uptake [GU]) at 1d, 14d, & 35d (n=6 per group) postnatal ages. In the hyt/hyt mice an increase in hxl mRNA was noted at 14d (40%; p < 0.05) & 35d (2-fold; p < 0.05), while a 50% increase in hxl protein levels (p < 0.05) was observed at 35d. In contrast, Hxl enzyme activity & H-2-DGU/mg declined only in the 14d hyt/hyt vs. Balb-C mice. We conclude that 1] hypoT post-translationally decreases brain hxl enzyme activity and 2-DGU at 14d postnatal age, similar to our previous observation of a decline in brain glucose transporter protein levels, 2] in response to the hypoT induced decline in brain GU & hxl activity, hxl mRNA & protein concentrations demonstrated a compensatory increase. We speculate that hypoT adversely affects brain GU by reducing brain glucose phosphorylation only at 14d, a period when a physiological thyroid hormone surge, and maximal brain growth and cellular maturation occurs, thereby explaining the development of neurological dysfunction.
[Supported by NIH HD-33997 & HL-52839]
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Khan, J., Rajakumar, R., Devaskar, U. et al. Primary hypothyroidism alters expression and function of the hexokinase I gene which mediates brain glucose phosphorylation. † 1390. Pediatr Res 41 (Suppl 4), 234 (1997). https://doi.org/10.1203/00006450-199704001-01409
Issue Date:
DOI: https://doi.org/10.1203/00006450-199704001-01409